MLB-1707

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMLB-1707
Drug Alias NameMLB-1707
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionC-X-C motif chemokine ligand 12 antagonistsC-X-C motif chemokine receptor 4 antagonists
TargetsC-X-C motif chemokine ligand 12C-X-C motif chemokine receptor 4
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesMainline Biosciences (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMainline Biosciences (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A